ES2038718T3 - TRANSDERMAL THERAPEUTIC SYSTEM FOR THE APPLICATION OF ACTIVE PRODUCTS ON THE SKIN. - Google Patents

TRANSDERMAL THERAPEUTIC SYSTEM FOR THE APPLICATION OF ACTIVE PRODUCTS ON THE SKIN.

Info

Publication number
ES2038718T3
ES2038718T3 ES198888109852T ES88109852T ES2038718T3 ES 2038718 T3 ES2038718 T3 ES 2038718T3 ES 198888109852 T ES198888109852 T ES 198888109852T ES 88109852 T ES88109852 T ES 88109852T ES 2038718 T3 ES2038718 T3 ES 2038718T3
Authority
ES
Spain
Prior art keywords
skin
transdermal therapeutic
therapeutic system
application
active products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888109852T
Other languages
Spanish (es)
Inventor
Frank Becher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2038718T3 publication Critical patent/ES2038718T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Radiation-Therapy Devices (AREA)
  • Massaging Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL INVENTO CONSISTE EN UN SISTEMA TERAPEUTICO TRANSDERMAL PARA SUMINISTRO DE SUSTANCIAS EN LA PIEL CON UNA CAPA POSTERIOR DIRIGIDA A LA PIEL, UN DEPOSITO DE SUSTANCIA, UN DISPOSITIVO DE MANDO DE SUMINISTRO DE SUSTANCIA POR EL SISTEMA Y UN DISPOSITIVO DE FIJACION ADHERENTE PARA EL SISTEMA TERAPEUTICO EN LA PIEL, QUE SE CARACTERIZA PORQUE EL DEPOSITO DE SUSTANCIA ES UN SISTEMA DE VARIAS CAMARAS DISCRETAS (14) MUESTRAN UNA O VARIAS SUSTANCIAS.THE INVENTION CONSISTS OF A TRANSDERMAL THERAPEUTIC SYSTEM FOR THE SUPPLY OF SUBSTANCES IN THE SKIN WITH A REAR LAYER DIRECTED TO THE SKIN, A SUBSTANCE DEPOSIT, A SUBSTANCE SUPPLY CONTROL DEVICE FOR THE ADJUSTMENT OF THE ADJUSTMENT OF THE FIXING SYSTEM IN SKIN, WHICH IS CHARACTERIZED BECAUSE THE SUBSTANCE DEPOSIT IS A SYSTEM OF SEVERAL DISCRETE CHAMBERS (14) SHOW ONE OR MULTIPLE SUBSTANCES.

ES198888109852T 1987-07-09 1988-06-21 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE APPLICATION OF ACTIVE PRODUCTS ON THE SKIN. Expired - Lifetime ES2038718T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873722775 DE3722775A1 (en) 1987-07-09 1987-07-09 TRANSDERMAL THERAPEUTIC SYSTEM

Publications (1)

Publication Number Publication Date
ES2038718T3 true ES2038718T3 (en) 1993-08-01

Family

ID=6331271

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888109852T Expired - Lifetime ES2038718T3 (en) 1987-07-09 1988-06-21 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE APPLICATION OF ACTIVE PRODUCTS ON THE SKIN.

Country Status (28)

Country Link
US (1) US5066494A (en)
EP (1) EP0298297B1 (en)
JP (1) JP2694984B2 (en)
KR (1) KR970008118B1 (en)
AT (1) ATE72760T1 (en)
AU (2) AU1952688A (en)
CA (1) CA1295202C (en)
CZ (1) CZ277745B6 (en)
DD (1) DD291008A5 (en)
DE (2) DE3722775A1 (en)
DK (1) DK168032B1 (en)
ES (1) ES2038718T3 (en)
FI (1) FI92285C (en)
GR (1) GR3004238T3 (en)
HR (1) HRP920829A2 (en)
HU (1) HU203985B (en)
IE (1) IE61788B1 (en)
IL (1) IL86904A (en)
MY (1) MY103740A (en)
NO (1) NO167628C (en)
NZ (1) NZ225241A (en)
PH (1) PH25175A (en)
PL (1) PL163843B1 (en)
PT (1) PT87936B (en)
SK (1) SK277758B6 (en)
WO (1) WO1989000437A1 (en)
YU (1) YU46983B (en)
ZA (1) ZA884671B (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
ES2017282A6 (en) * 1989-07-28 1991-01-16 Aguilera Franco Maria Dressing for transcutaneous application of active substances for therapeutic or cosmetic purposes.
DE4001034A1 (en) * 1990-01-16 1991-07-18 Eberhard Landau Sticking plaster for treatment of warts - has adhesive side with removable protective foil and contg. vitamin=C
JP3115625B2 (en) * 1991-03-30 2000-12-11 帝國製薬株式会社 Topical patch containing lidocaine
US5231977A (en) * 1991-09-11 1993-08-03 Graston David A Tools and method for performing soft tissue massage
US5707346A (en) * 1991-09-11 1998-01-13 Grastech, Inc. System and method for performing soft tissue massage therapy
FR2686505A1 (en) * 1992-01-29 1993-07-30 Lhd Lab Hygiene Dietetique PROCESS FOR THE MANUFACTURE OF A DRESSING WITH THINNED EDGES.
DK170792B1 (en) * 1992-08-27 1996-01-22 Coloplast As Skin plate product for dosing one or more medications
DE4316751C1 (en) * 1993-05-19 1994-08-04 Lohmann Therapie Syst Lts Method and device for producing a transdermal therapy system for the administration of active substances to the skin in the form of a flat multi-chamber or multi-chamber channel system
DE59509232D1 (en) * 1994-02-18 2001-06-13 Drossapharm Ag Basel Transdermal therapeutic system
US5665452A (en) * 1994-03-03 1997-09-09 The Procter & Gamble Company Three-dimensional, macroscopically expanded, apertured laminate webs
US5505958A (en) * 1994-10-31 1996-04-09 Algos Pharmaceutical Corporation Transdermal drug delivery device and method for its manufacture
DE29514849U1 (en) * 1995-09-15 1995-11-16 Weyergans, Rudolf, 52355 Düren Cellulite patch
DE19600959A1 (en) * 1996-01-12 1997-07-17 Amp Holland Joint section for porous fibres with high diffusivity for two fluids
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6269820B1 (en) 1998-02-26 2001-08-07 Xomed Surgical Products, Inc. Method of controlling post-operative leakage associated with tumescent liposuction
DE19900645C2 (en) * 1999-01-11 2003-03-20 Deotexis Inc Transdermal therapeutic system
GB2353219B (en) * 1999-08-16 2004-02-11 Johnson & Johnson Medical Ltd Easy to remove adhesive sheets
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
JP2004528900A (en) * 2001-04-20 2004-09-24 アルザ・コーポレーシヨン Microprojection array with coating containing beneficial agent
US20050118245A1 (en) * 2002-03-27 2005-06-02 Wilsmann Klaus M. Assembled unit consisting of individually separable, transdermal, therapeutic systems
DE10213772A1 (en) * 2002-03-27 2003-10-09 Gruenenthal Gmbh Cohesive unit of singular transdermal therapeutic systems
MY141815A (en) * 2003-04-30 2010-06-30 Purdue Pharma Lp Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
US7182955B2 (en) * 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
JP5456234B2 (en) * 2003-06-30 2014-03-26 アルザ・コーポレーシヨン Formulations for coated microprojections containing non-volatile counterions
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
US8524272B2 (en) * 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
US9205062B2 (en) * 2004-03-09 2015-12-08 Mylan Pharmaceuticals, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery
DE102004020463A1 (en) * 2004-04-26 2005-11-10 Grünenthal GmbH Drug delivery system consisting of a drug-containing patch and at least one Wirkstoffabgaberegulierungsmittel
WO2005105009A1 (en) * 2004-04-26 2005-11-10 Cassel Douglas R Wound treatment patch for alleviating pain
BRPI0509788A (en) 2004-05-13 2007-10-23 Alza Corp apparatus and method for transdermal delivery of parathyroid hormone agents
EP1796651B1 (en) * 2004-08-20 2015-05-20 3M Innovative Properties Company Transdermal drug delivery device with translucent protective film
DE102005004924A1 (en) * 2005-02-02 2006-08-03 Paul Hartmann Ag Device for treating trophic disorders in the skin or in a wound comprises a first layer which lies on the skin or on the wound and distances from the latter a reservoir of aqueous carbon dioxide solution
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US20100068283A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex VIVO modifiable particle or polymeric material medicament carrier
US20100069887A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Multiple chamber ex vivo adjustable-release final dosage form
US8690841B2 (en) * 2009-07-09 2014-04-08 R. Gary Diaz Wound care system
US9861590B2 (en) * 2010-10-19 2018-01-09 Covidien Lp Self-supporting films for delivery of therapeutic agents
MX355295B (en) 2011-04-04 2018-04-12 Procter & Gamble Personal care article.
WO2013025760A1 (en) 2011-08-15 2013-02-21 The Procter & Gamble Company Personal care articles having multiple zones with compliant personal care compositions
CN104202987B (en) 2011-08-15 2017-09-01 宝洁公司 Personal nursing method
MX355506B (en) 2013-06-27 2018-04-19 Procter & Gamble Preserving personal care compositions.
IL264911A (en) * 2019-02-19 2020-08-31 Univ Ramot A patch and method of manufacturing same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA930668A (en) * 1969-04-01 1973-07-24 Zaffaroni Alejandro Bandage for administering drugs
US3814095A (en) * 1972-03-24 1974-06-04 H Lubens Occlusively applied anesthetic patch
IE54286B1 (en) * 1983-01-18 1989-08-16 Elan Corp Plc Drug delivery device
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
ATE42901T1 (en) * 1984-03-05 1989-05-15 Nitto Denko Corp ADHESIVE MEDICATION FOR PERCUTANEOUS ABSORPTION.
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
EP0252459A1 (en) * 1986-07-07 1988-01-13 Schering Corporation Compartmentalized transdermal delivery system
US5032464A (en) * 1986-10-27 1991-07-16 Burlington Industries, Inc. Electrodeposited amorphous ductile alloys of nickel and phosphorus

Also Published As

Publication number Publication date
JPH02501039A (en) 1990-04-12
NO167628B (en) 1991-08-19
FI891076A0 (en) 1989-03-07
EP0298297B1 (en) 1992-02-26
YU132688A (en) 1991-04-30
FI891076A (en) 1989-03-07
AU662341B2 (en) 1995-08-31
IL86904A (en) 1993-08-18
JP2694984B2 (en) 1997-12-24
NO890939D0 (en) 1989-03-06
WO1989000437A1 (en) 1989-01-26
KR890701164A (en) 1989-12-19
FI92285B (en) 1994-07-15
AU1952688A (en) 1989-02-13
NZ225241A (en) 1991-10-25
AU2120392A (en) 1992-11-19
ATE72760T1 (en) 1992-03-15
NO167628C (en) 1991-11-27
CS488088A3 (en) 1992-12-16
HUT53542A (en) 1990-11-28
PH25175A (en) 1991-03-27
DK112989A (en) 1989-03-08
GR3004238T3 (en) 1993-03-31
US5066494A (en) 1991-11-19
CA1295202C (en) 1992-02-04
DE3722775A1 (en) 1989-01-19
PL273619A1 (en) 1989-03-20
NO890939L (en) 1989-03-06
KR970008118B1 (en) 1997-05-21
HRP920829A2 (en) 1994-04-30
CZ277745B6 (en) 1993-04-14
IE882080L (en) 1989-01-09
DK112989D0 (en) 1989-03-08
YU46983B (en) 1994-09-09
EP0298297A1 (en) 1989-01-11
DK168032B1 (en) 1994-01-24
MY103740A (en) 1993-09-30
ZA884671B (en) 1989-03-29
PT87936A (en) 1989-06-30
DE3868549D1 (en) 1992-04-02
DD291008A5 (en) 1991-06-20
PL163843B1 (en) 1994-05-31
FI92285C (en) 1994-10-25
HU203985B (en) 1991-11-28
SK277758B6 (en) 1994-12-07
PT87936B (en) 1993-09-30
IE61788B1 (en) 1994-11-30
IL86904A0 (en) 1988-11-30

Similar Documents

Publication Publication Date Title
ES2038718T3 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE APPLICATION OF ACTIVE PRODUCTS ON THE SKIN.
MX9207263A (en) SYSTEM FOR THE SUPPLY OF AN ACTIVE SUBSTANCE FOR SUSTAINED LIBERATION.
ES2055692T3 (en) THERAPEUTIC SYSTEM IN FLAT FORM, PROCEDURE FOR ITS PREPARATION AND EMPLOYMENT.
MX9203755A (en) IONTOPHORETICAL SUPPLY DEVICE FOR DRUGS OR THERAPEUTIC AGENTS, EQUIPPED WITH AN ADHESIVE OF ELECTRO-TRANSPORTATION.
NO883918L (en) COATING FORMULATION FOR BIOACTIVE SUBSTANCES WITH CONTROLLED RELEASE.
ATE121302T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM WITH THE ACTIVE INGREDIENT TULOBUTEROL.
DE59405920D1 (en) ACTIVE PLASTER
ES2030026T3 (en) TRANSDERMAL THERAPEUTIC SYSTEM, ITS APPLICATION AND PROCEDURE FOR ITS MANUFACTURE.
KR890701076A (en) Temperature-controlled active drug dispenser
ES2060825T3 (en) A THERAPEUTIC SYSTEM FOR DELAYED AND CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES BY VIA PERCUTANEA OR THROUGH THE MUCOSA.
ES2148838T3 (en) ANTI-SENSE OLIGONUCLEOTIDES AGAINST THE ALP REGULATORY SUBUNIT OF PROPETIN KINASE, DEPENDENT ON CAMP FOR THE TREATMENT OF CANCER.
YU49490A (en) PROCEDURE FOR MAKING PATCHES AS A TRANSDERMAL SYSTEM FOR ADMINISTRATION OF ACTIVE MATERIALS ON THE SKIN WITH RELEASE OF ACTIVE MATERIAL AS WELL AS APPLICATION
ES2027720T3 (en) PESTS CONTAINING ACTIVE SUBSTANCES FOR THE CONTROLLED ADMINISTRATION OF ACTIVE SUBSTANCES THROUGH THE SKIN.
DK0457849T3 (en) Electrotransport adhesive
ES288234Y (en) DEVICE FOR AESTHETIC SKIN TREATMENT
BR9608255A (en) Transdermal therapeutic system (stt) for testosterone administration
AR001070A1 (en) Application form for the supply of (s) -3-methyl-5- (1-methyl-2-pyrrolidenyl) -isoxazole or any of its pharmaceutically suitable salts and procedure for preparing the application form
MX9204286A (en) AGENTS FOR SEED TREATMENT.
DE68906132D1 (en) FLECAINID ACETATE CONTAINING MEDICINAL PRODUCT WITH DELAYED ACTIVE SUBSTANCE RELEASE.
AR019948A1 (en) PATCH CONTAINING ACTIVE SUBSTANCE, FOR THE CONTROLLED ISSUANCE OF ESTRADIOL OR ITS PHARMACEUTICALLY INOFENSIVE DERIVATIVES, AND THE USES OF THE PATCH
ES1008284Y (en) DEVICE FOR SPILLING, DOSAGE AND CONTROLLED SUPPLY OF DETERGENTS AND SIMILAR PRODUCTS.
ES295113Y (en) DEVICE FOR THE INDIVIDUALIZED SUPPLY OF LONG ARTICLES OF SMALL SECTION.
ES1004341Y (en) PERFECTED DEVICE FOR SERIGRAPHING FOOTWEAR SOLES.
AR240247Q (en) PREPARATION PROCEDURE FOR ANTIESPASMODIC PRODUCTS TO FIX ON THE SKIN, PARTICULARLY AGAINST MUSCULAR SPASM.
ES1003394Y (en) PERFECTED PLOW HOLDER FOR TILLING INTERCEPAS AND SIMILAR.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 298297

Country of ref document: ES